Search Results for: stem cell therapy

ISSCR KO’d in round one versus unproven clinics: where’s the FDA?

/ / 3 Comments

What is ISSCR doing about unproven stem cell clinics? One of the greatest and most infuriating ironies of the stem cell-based regenerative medicine universe is that while the FDA strictly regulates the progress of therapy development by Advanced Cell Technology (ACT) and Geron and other legitimate companies, at the same time mysteriously the FDA essentially […]

ISSCR KO’d in round one versus unproven clinics: where’s the FDA? Read More »

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

/
advanced-cell-technology

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness Read More »

Tumorigenicity and Pluripotency teased apart? Not yet for Myc

/
Fig.-5-Nakagawa-et-al.-Myc-in-cancer-and-IPScs

A paper just came out in PNAS entitled “Promotion of direct reprogramming by transformation-deficient Myc“. The main thrust of this paper is that the tumorigenic and pluripotency-related functions of Myc could be separated. It focused primarily on the lesser studied LMyc. The topic of the intertwined good (pluripotency) and bad (tumorigenicity) functions of Myc, addressed

Tumorigenicity and Pluripotency teased apart? Not yet for Myc Read More »